menu
    • menu

    Company profile for Bora Pharmaceuticals

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bora Pharmaceuticals is a premier global contract development and manufacturing organization (CDMO), specializing in formulation development, clinical and commercial manufacturing and packaging of complex oral solid dose, liquid, and semi-solid pharmaceutical products for clinical and commercial uses.
    From cell-line development and formulation to analytical services and clinical cGMP manufacturing, Bora now provides tailo...
    Bora Pharmaceuticals is a premier global contract development and manufacturing organization (CDMO), specializing in formulation development, clinical and commercial manufacturing and packaging of complex oral solid dose, liquid, and semi-solid pharmaceutical products for clinical and commercial uses.
    From cell-line development and formulation to analytical services and clinical cGMP manufacturing, Bora now provides tailored development and manufacturing services to biologics developers. Bora operates nine cGMP manufacturing sites in Asia, Canada, and the United States, and delivers to over 100 markets worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bora PharmaceuticalsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    6F, No 69, Xing'ai Road, Neihu District, Taipei City 114
    Telephone
    Telephone
    +1 844636-BORA (2672) // +1 616636-BORA (2672)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.boracdmo.com
    Linkedin
    Linkedin
    https://in.linkedin.com/company/borapharmaceuticals
    youtube
    YouTube
    http://www.youtube.com/@groupbora5676
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Upsher-Smith Introduces Generic Ciprodex Otic Suspension
    Upsher-Smith Introduces Generic Ciprodex Otic Suspension

    06 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/upsher-smith-launches-generic-version-of-ciprodex-ciprofloxacin-0-3-and-dexamethasone-0-1-sterile-otic-suspension-302734882.html

    PR NEWSWIRE
    06 Apr 2026
    Share Share
    CDMO Bora inks $250M manufacturing deal with GSK
    CDMO Bora inks $250M manufacturing deal with GSK

    24 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/cdmo-bora-leverages-growing-north-american-footprint-250m-five-year-manufacturing

    FIERCE PHARMA
    24 Feb 2026
    Share Share
    Bora Biologics Unveils $30M San Diego Manufacturing Expansion
    Bora Biologics Unveils $30M San Diego Manufacturing Expansion

    26 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-26/bora-biologics-celebrates-opening-of-30-million-san-diego-manufacturing-expansion

    PHARMIWEB
    26 Jan 2026
    Share Share
    Bora Pharma, Corealis Pharma Ally For Oral Solid Dose Development
    Bora Pharma, Corealis Pharma Ally For Oral Solid Dose Development

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bora-pharmaceuticals-and-corealis-pharma-forge-strategic-alliance-to-deliver-seamless-end-to-end-oral-solid-dose-development-302635969.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share
    Bora Pharmaceuticals To Scale Supply Of Oncology Therapy
    Bora Pharmaceuticals To Scale Supply Of Oncology Therapy

    27 Oct 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/bora-pharmaceuticals-to-scale-supply-of-oncology-therapy/

    CONTRACTPHARMA
    27 Oct 2025
    Share Share
    Bora Biologics Partners With Invagen Pharma To Produce
    Bora Biologics Partners With Invagen Pharma To Produce

    25 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/bora-biologics-to-manufacture-nypozitm-at-san-diego-facility-in-partnership-with-inva-1078073

    ACCESSWIRE
    25 Sep 2025
    Share Share

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Packaging

    Click here to discover the service providers for Packaging

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-01-28

    Bora Pharmaceuticals

    City : Mississauga

    State :

    Country/Area : Canada

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-01-28

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2024-07-25

    Bora Pharmaceuticals

    City : Baltimore

    State : Maryland

    Country/Area : U.S.A

    Zip : 21230

    District :

    Center :

    Project Area : Blood and Blood Products

    District Decision : No Action Indicated

    Inspection End Date : 2024-07-25

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-08-10

    Bora Pharmaceuticals

    City : Baltimore

    State : Maryland

    Country/Area : U.S.A

    Zip : 21230

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-08-10

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-08-30

    Bora Pharmaceuticals

    City : Maple Grove

    State : Minnesota

    Country/Area : U.S.A

    Zip : 55369

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2022-08-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Official Action Indicated

    Inspection End Date : 2022-02-18

    Bora Pharmaceuticals

    City : Baltimore

    State : Maryland

    Country/Area : U.S.A

    Zip : 21230

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Official Action Indicated

    Inspection End Date : 2022-02-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-04-16

    Bora Pharmaceuticals

    City : Baltimore

    State : Maryland

    Country/Area : U.S.A

    Zip : 21230

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2021-04-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-11-07

    Bora Pharmaceuticals

    City : Mississauga

    State :

    Country/Area : Canada

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2019-11-07

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-05-10

    Bora Pharmaceuticals

    City : Baltimore

    State : Maryland

    Country/Area : U.S.A

    Zip : 21230

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2019-05-10

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-19

    Bora Pharmaceuticals

    City : Maple Grove

    State : Minnesota

    Country/Area : U.S.A

    Zip : 55369

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    ICMD China
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    ICMD China
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-19

    Bora Pharmaceuticals

    City : Maple Grove

    State : Minnesota

    Country/Area : U.S.A

    Zip : 55369

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2018-12-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Others

    read-more
    read-more

    01

    Inspected

    RoW
    ICMD China
    Not Confirmed

    Bora Pharmaceuticals

    Inspection : Health Canada

    About the Company : Bora Pharmaceuticals is a premier global contract development and manufacturing organization (CDMO),...

    Bora Pharmaceuticals is a premier global contract development and manufacturing organization (CDMO), specializing in formulation development, clinical and commercial manufacturing and packaging of complex oral solid dose, liquid, and semi-solid pharmaceutical products for clinical and commercial uses.
    From cell-line development and formulation to analytical services and clinical cGMP manufacturing, Bora now provides tailored development and manufacturing services to biologics developers. Bora operates nine cGMP manufacturing sites in Asia, Canada, and the United States, and delivers to over 100 markets worldwide.

    Country : Taiwan

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search